TransDigm Group 8-K Report, Corporate Update (May 28, 2024)

TransDigm Group (NYSE: TDG) announced on May 28, 2024 a definitive agreement to acquire Raptor Labs Holdco, LLC (Raptor Scientific), a portfolio company of L Squared Capital Partners, for approximately $655 million^a in cash, including certain tax benefits.

Raptor Scientific is a global manufacturer of complex test and measurement solutions, primarily serving aerospace and defense end markets, with nearly all revenue derived from proprietary, highly engineered products that carry significant aftermarket content. The company employs about 170 people across five U.S. manufacturing sites and is expected to generate roughly $90 million^b in revenue in calendar 2024. For investors, the deal is a typical TransDigm bolt-on acquisition consistent with its stated strategy of acquiring proprietary aerospace and defense businesses that can generate value in line with its long-term private equity-like return objectives, as management described.

At roughly $655 million^c against about $90 million of expected 2024 revenue, the implied purchase price is around 7.3x forward revenue; the filing does not disclose EBITDA, margins, or expected accretion, so the valuation multiple on earnings cannot be assessed from this document. The transaction is to be funded from existing cash on hand rather than new debt or equity issuance, which limits dilution and leverage concerns, though it does reduce liquidity somewhat. Closing is subject to U.S. regulatory approvals and customary closing conditions, and the filing gives no expected closing timeline.

The disclosure is furnished under Item 8.01 (Other Events) rather than as a material definitive agreement, indicating the company did not view it as a transaction requiring Item 1.01 treatment. Investors should monitor regulatory progress and any subsequent disclosure of financial terms, purchase accounting, and integration plans.